601 related articles for article (PubMed ID: 19633196)
1. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease.
Blurton-Jones M; Kitazawa M; Martinez-Coria H; Castello NA; Müller FJ; Loring JF; Yamasaki TR; Poon WW; Green KN; LaFerla FM
Proc Natl Acad Sci U S A; 2009 Aug; 106(32):13594-9. PubMed ID: 19633196
[TBL] [Abstract][Full Text] [Related]
2. Neural stem cell transplants improve cognitive function without altering amyloid pathology in an APP/PS1 double transgenic model of Alzheimer's disease.
Zhang W; Wang PJ; Sha HY; Ni J; Li MH; Gu GJ
Mol Neurobiol; 2014 Oct; 50(2):423-37. PubMed ID: 24481678
[TBL] [Abstract][Full Text] [Related]
3. Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss.
Ager RR; Davis JL; Agazaryan A; Benavente F; Poon WW; LaFerla FM; Blurton-Jones M
Hippocampus; 2015 Jul; 25(7):813-26. PubMed ID: 25530343
[TBL] [Abstract][Full Text] [Related]
4. Neural stem cell transplantation improves learning and memory by protecting cholinergic neurons and restoring synaptic impairment in an amyloid precursor protein/presenilin 1 transgenic mouse model of Alzheimer's disease.
Zhu Q; Zhang N; Hu N; Jiang R; Lu H; Xuan A; Long D; Chen Y
Mol Med Rep; 2020 Mar; 21(3):1172-1180. PubMed ID: 31922229
[TBL] [Abstract][Full Text] [Related]
5. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
6. Genetic knockdown of brain-derived neurotrophic factor in 3xTg-AD mice does not alter Aβ or tau pathology.
Castello NA; Green KN; LaFerla FM
PLoS One; 2012; 7(8):e39566. PubMed ID: 22870188
[TBL] [Abstract][Full Text] [Related]
7. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
[TBL] [Abstract][Full Text] [Related]
8. Conditional BDNF Delivery from Astrocytes Rescues Memory Deficits, Spine Density, and Synaptic Properties in the 5xFAD Mouse Model of Alzheimer Disease.
de Pins B; Cifuentes-Díaz C; Farah AT; López-Molina L; Montalban E; Sancho-Balsells A; López A; Ginés S; Delgado-García JM; Alberch J; Gruart A; Girault JA; Giralt A
J Neurosci; 2019 Mar; 39(13):2441-2458. PubMed ID: 30700530
[TBL] [Abstract][Full Text] [Related]
9. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
[TBL] [Abstract][Full Text] [Related]
10. Amyloid and tau neuropathology differentially affect prefrontal synaptic plasticity and cognitive performance in mouse models of Alzheimer's disease.
Lo AC; Iscru E; Blum D; Tesseur I; Callaerts-Vegh Z; Buée L; De Strooper B; Balschun D; D'Hooge R
J Alzheimers Dis; 2013; 37(1):109-25. PubMed ID: 23788007
[TBL] [Abstract][Full Text] [Related]
11. Regulation and effects of neurotrophic factors after neural stem cell transplantation in a transgenic mouse model of Alzheimer disease.
Li B; Gao Y; Zhang W; Xu JR
J Neurosci Res; 2018 May; 96(5):828-840. PubMed ID: 29114922
[TBL] [Abstract][Full Text] [Related]
12. SPG302 Reverses Synaptic and Cognitive Deficits Without Altering Amyloid or Tau Pathology in a Transgenic Model of Alzheimer's Disease.
Trujillo-Estrada L; Vanderklish PW; Nguyen MMT; Kuang RR; Nguyen C; Huynh E; da Cunha C; Javonillo DI; Forner S; Martini AC; Sarraf ST; Simmon VF; Baglietto-Vargas D; LaFerla FM
Neurotherapeutics; 2021 Oct; 18(4):2468-2483. PubMed ID: 34738197
[TBL] [Abstract][Full Text] [Related]
13. α7 Nicotinic receptor agonist enhances cognition in aged 3xTg-AD mice with robust plaques and tangles.
Medeiros R; Castello NA; Cheng D; Kitazawa M; Baglietto-Vargas D; Green KN; Esbenshade TA; Bitner RS; Decker MW; LaFerla FM
Am J Pathol; 2014 Feb; 184(2):520-9. PubMed ID: 24269557
[TBL] [Abstract][Full Text] [Related]
14. In vitro validation of effects of BDNF-expressing mesenchymal stem cells on neurodegeneration in primary cultured neurons of APP/PS1 mice.
Song MS; Learman CR; Ahn KC; Baker GB; Kippe J; Field EM; Dunbar GL
Neuroscience; 2015 Oct; 307():37-50. PubMed ID: 26297896
[TBL] [Abstract][Full Text] [Related]
15. Reversal of memory and neuropsychiatric symptoms and reduced tau pathology by selenium in 3xTg-AD mice.
Van der Jeugd A; Parra-Damas A; Baeta-Corral R; Soto-Faguás CM; Ahmed T; LaFerla FM; Giménez-Llort L; D'Hooge R; Saura CA
Sci Rep; 2018 Apr; 8(1):6431. PubMed ID: 29691439
[TBL] [Abstract][Full Text] [Related]
16. Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction.
Corona C; Masciopinto F; Silvestri E; Viscovo AD; Lattanzio R; Sorda RL; Ciavardelli D; Goglia F; Piantelli M; Canzoniero LM; Sensi SL
Cell Death Dis; 2010 Oct; 1(10):e91. PubMed ID: 21368864
[TBL] [Abstract][Full Text] [Related]
17. Age and sex differences in motivation and spatial working memory in 3xTg-AD mice in the Hebb-Williams maze.
Fertan E; Wong AA; Vienneau NA; Brown RE
Behav Brain Res; 2019 Sep; 370():111937. PubMed ID: 31121220
[TBL] [Abstract][Full Text] [Related]
18. Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer disease.
Liang B; Duan BY; Zhou XP; Gong JX; Luo ZG
J Biol Chem; 2010 Sep; 285(36):27737-44. PubMed ID: 20595388
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Early Growth Response 1 in the Hippocampus Alleviates Neuropathology and Improves Cognition in an Alzheimer Model with Plaques and Tangles.
Qin X; Wang Y; Paudel HK
Am J Pathol; 2017 Aug; 187(8):1828-1847. PubMed ID: 28641077
[TBL] [Abstract][Full Text] [Related]
20. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]